- $84.95bn
- $87.50bn
- $10.50bn
- 87
- 17
- 93
- 72
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,569 | 5,806 | 6,919 | 9,212 | 10,496 |
Cost of Revenue | |||||
Gross Profit | 2,699 | 3,357 | 4,147 | 5,789 | 6,461 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,180 | 4,327 | 4,430 | 5,558 | 6,515 |
Operating Profit | 1,389 | 1,480 | 2,488 | 3,654 | 3,981 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,296 | 1,317 | 2,360 | 3,489 | 3,789 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,156 | 1,215 | 2,077 | 3,322 | 3,387 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,176 | 1,217 | 2,078 | 3,322 | 3,387 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,176 | 1,217 | 2,078 | 3,322 | 3,387 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.37 | 9.38 | 13.4 | 23 | 25.1 |
Dividends per Share |